Anthropic's $2T IPO Target Drives AI Listing Wave

The first full week after the U.S. Labor Day holiday has brought an unusually crowded artificial-intelligence IPO pipeline into focus. According to a Bloomberg report syndicated across Tribune Publishing titles on September 10, 2026, Anthropic PBC is the anchor of a late-year listing wave, reportedly seeking to match or top the record $86 billion-plus IPO completed by Elon Musk's SpaceX in June 2026. Alongside Anthropic, AI cloud computing firm Nscale, power supplier Aggreko Plc, and consumer medical technology maker Oura Health Oy are preparing to enter the public markets, while OpenAI is expected to launch one of the biggest-ever listings this year or next. The grouping matters because it shifts IPO leadership from pure AI model developers to the physical and infrastructure layers of the AI economy. Nscale represents the data-center compute layer, Aggreko supplies power and cooling assets that data centers require, and Oura Health brings AI into consumer wearables and health monitoring. Deutsche Bank technology investment banking chair Ajay Shah noted that these areas—data center space, power cooling, and consumer health—would 'really peak investor interest.' That framing suggests underwriters are betting the public market wants a broader set of AI exposure than a single frontier-model company, even if Anthropic remains the highest-profile name. The pipeline is forming despite visible macro headwinds. Sources cite rising oil prices, war in the Middle East and Ukraine, and the potential for higher interest rates as reasons some issuers are cautious. Class V Group founder Lise Buyer said on Bloomberg Deals that most companies are 'heads down focused on getting the numbers in order' rather than trying to time around Anthropic because 'timing is always uncertain.' Renaissance Capital senior strategist Matt Kennedy added a dual observation: some companies are waiting for optimal conditions, while others see the market as 'good enough.' That split could produce uneven listing performance if macro conditions deteriorate. The valuation debate is the sharpest point of tension in this IPO cluster. SpaceX's June 2026 IPO, at more than $86 billion, set a precedent in which public investors accepted a valuation that depended on earnings that may not materialize for years. Kennedy said Anthropic can point to that precedent to justify its 'supposed $2 trillion valuation,' but that number is attributed to market chatter rather than an official filing or confirmed pricing. If Anthropic prices anywhere near that level, it would dwarf SpaceX and become one of the largest listings in history, but it would also test whether public markets are willing to underwrite theoretical future earnings across an entire AI capital-expenditure complex. For the other issuers—Nscale, Aggreko, and Oura Health—the practical question is whether they can differentiate themselves enough to avoid being overshadowed by Anthropic and OpenAI. Their presence signals that the AI IPO trade is expanding beyond software into energy, hardware, and consumer health. Investors will likely scrutinize revenue durability, power constraints, and data-center utilization more closely than in previous software-led IPO cycles. The forward-looking view is that the fall 2026 IPO season will serve as a stress test for private AI valuations and late-stage liquidity. If Anthropic and OpenAI price successfully, it could unlock a broader wave of infrastructure and application-layer IPOs. If macro risks intensify or the first deals trade poorly, the pipeline could stall. The next catalysts to watch are formal filings, pricing terms, and whether the queue of AI-adjacent issuers can convert investor enthusiasm into valuations that survive the first public trading days.